Report Categories
View AllRecent Articles
View All
Why Is United Unfi Stock Outperforming Recently Price At 46.26 Down 2.47 20260404
How Does Earnings Affect First Fnwb Stock Fnwb Q4 Earnings Misses Estimates By 0.14 20260413 1
Is Innovative Issc Stock Stable Now Price At 21.76 Down 3.37 20260406
Is Ofa Group Ofal Stock Trending Down Ofal Q2 2025 Earnings Ofa Group Posts 0.05 Eps No Revenue Or Estimates 20260406 1
AIRE reAlpha shares plunge 138 despite earnings beat and 376 revenue surge
How Alpha Met AMR adapts when conditions change 189 20260507
What PrimeEnergy PNRG does that makes it resilient Momentum Fading 20260507
Templeton TEI Stock Trend Trade 091 20260416
What revision trend Nautilus Biotechnology NAUT Spikes 20260501
Why TransCanada TCPA is trading below its true worth Buying Pressure 20260503
BKH Black Hills falls 144 following a narrow Q4 2025 EPS miss that landed 1 below consensus forecasts
Is Amneal AMRX stock testing support Amneal posts 557 pct EPS beat vs street estimates
FibroBiologics FBLG Slides 370 as Selling Pressure Mounts 20260520
NeuroSense Therapeutics NRSN Slides 456 as Support Levels Are Tested
Olin Corporation OLN Surges 135 Nearing 2763 Resistance 20260520
What Cellectis CLLSs 083 Jump Means for Investors 20260520
SpaceX IPO Opens to Retail Investors via Major Brokerage Platforms
Fitness Apps Challenge Traditional Personal Training Market Implications and Investment Perspective
Safepoint Insurance Targets 116 Billion Valuation in Upcoming US IPO
Federal Reserve Holds Rates Steady Amidst Internal Divisions Powell Confirms He Will Remain as Governor
Regional Powers Cannot Substitute US For Gulfs Defense Against Iran
SpaceX Postpones Starship Launch as Potential Mega Share Sale Looms
NSIT Q1 2026 Earnings Strong EPS Beat Drives Stock Up 31
Paramount Skydance Corporation PSKY Q1 2026 Earnings EPS Surges Past Expectations Stock Rises
Finward Bancorp FNWD Q1 2026 Earnings EPS Misses Expectations but Stock Ticks Higher
NanoX Imaging Ltd NNOX Q4 2025 Earnings Significant EPS Miss Amid Ongoing Commercialization Efforts
CEPT Q1 2026 Earnings Strong EPS Beat Drives Share Price Uplift
CNP Q1 2026 Earnings Slight EPS Miss Amidst Operational Progress
Protagonist Therapeutics PTGX Hovering Near Resistance After Modest Pullback
GoodRx GDRX Holds Above Support After 288 Gain Key Levels in Focus
Xperi Inc XPER Edges Higher A Cautious Recovery from Support Levels
EHI Western Asset Global High Income Fund Edges Higher Holding Near Key Support
Kymera Therapeutics KYMR Slips Over 2 as Biotech Shares Retreat Support Levels in Focus